Antibiotice Ia (ATB.RO) stock: key figures, P/E, revenue and dividend

Health Care · Romania · ISIN ROATBIACNOR9

Price
1.86 RON
Market cap
1.25 bn RON
P/E (2025)
24.17
P/S (2025)
1.94
Dividend yield
1.92 %
Net margin
8.02 %
Return on equity (ROE)
5.55 %
Return on assets (ROA)
3.72 %

Antibiotice Ia financials

Fiscal year20242025
Revenue675.01 m RON645.28 m RON
Gross profit452.01 m RON422.87 m RON
Operating income103.96 m RON61.23 m RON
EBIT107.65 m RON64.61 m RON
Net income102.20 m RON51.77 m RON
Diluted EPS – continuing operations0.15 RON0.08 RON

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Antibiotice Ia

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, pessaries, and suppositories. It offers active pharmaceutical ingredients. The company exports its products to approximately 70 countries. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.